Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.22 - $0.5 $1,914 - $4,350
-8,700 Reduced 7.4%
108,857 $32,000
Q1 2023

May 12, 2023

BUY
$0.36 - $0.63 $2,117 - $3,706
5,883 Added 5.27%
117,557 $43,000
Q4 2022

Feb 09, 2023

SELL
$0.41 - $18.6 $11,998 - $544,329
-29,265 Reduced 20.76%
111,674 $53,000
Q3 2022

Nov 09, 2022

SELL
$0.57 - $34.65 $5,273 - $320,547
-9,251 Reduced 6.16%
140,939 $121,000
Q2 2022

Aug 11, 2022

BUY
$0.85 - $1.41 $6,975 - $11,570
8,206 Added 5.78%
150,190 $140,000
Q1 2022

May 12, 2022

BUY
$1.16 - $2.5 $57,651 - $124,250
49,700 Added 53.86%
141,984 $187,000
Q4 2021

Feb 11, 2022

BUY
$2.46 - $8.74 $150,618 - $535,123
61,227 Added 197.14%
92,284 $227,000
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $318,775 - $586,921
-62,505 Reduced 66.81%
31,057 $265,000
Q2 2021

Aug 10, 2021

BUY
$3.95 - $6.88 $369,569 - $643,706
93,562 New
93,562 $599,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $52.8M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.